Analysts Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $105.33

U.S. Physical Therapy, Inc. (NYSE:USPH) has earned an average recommendation of “Moderate Buy” from the seven analysts that are covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $105.3333.

A number of research firms have recently commented on USPH. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, October 8th. JPMorgan Chase & Co. dropped their price target on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a research report on Monday, November 24th. Barrington Research reissued an “outperform” rating and issued a $103.00 price target on shares of U.S. Physical Therapy in a report on Friday, October 24th. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Monday, December 15th. Finally, Wall Street Zen downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st.

Institutional Trading of U.S. Physical Therapy

A number of hedge funds have recently bought and sold shares of USPH. CIBC Bancorp USA Inc. purchased a new stake in U.S. Physical Therapy in the 3rd quarter worth approximately $331,000. Advisory Services Network LLC acquired a new position in shares of U.S. Physical Therapy in the third quarter worth $39,000. Morningstar Investment Management LLC purchased a new stake in shares of U.S. Physical Therapy during the third quarter worth $503,000. XTX Topco Ltd acquired a new stake in U.S. Physical Therapy during the third quarter valued at $632,000. Finally, Millennium Management LLC purchased a new position in U.S. Physical Therapy in the third quarter valued at about $243,000.

U.S. Physical Therapy Trading Down 0.4%

NYSE:USPH opened at $81.11 on Friday. U.S. Physical Therapy has a 1 year low of $62.77 and a 1 year high of $93.50. The business has a fifty day moving average of $78.64 and a 200-day moving average of $80.34. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.20 and a current ratio of 1.20. The stock has a market cap of $1.23 billion, a price-to-earnings ratio of 34.08, a PEG ratio of 3.78 and a beta of 1.32.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. U.S. Physical Therapy had a net margin of 5.71% and a return on equity of 8.62%. The company had revenue of $140.66 million for the quarter. Equities analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Monday, November 17th were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Monday, November 17th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.2%. U.S. Physical Therapy’s payout ratio is 75.63%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.